Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
2
33%
Ph phase_3
3
50%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 33 (60.0%)

Trials by Status

terminated117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial

NCT00464971
completedphase_3

Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

NCT00465192
terminatedphase_3

Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

NCT00560924
completed

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

NCT01507454
completedphase_1

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

NCT01486979
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00464971Phase 3

Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial

Completed
NCT00465192Phase 3

Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

Completed
NCT00560924Phase 3

Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

Terminated
NCT01507454

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Completed
NCT01486979Phase 1

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

Completed
NCT01085877Phase 1

Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6